Neuranix
Rosita Genovese has a diverse work experience in the field of quality and regulatory management. Rosita is currently working at Neuranix as a Quality and Regulatory Manager, a position they have held since September 2021. Prior to this role, they were a Quality and Regulatory Coordinator at Neuranix from January 2021 to September 2021.
Before joining Neuranix, Rosita worked at ServerNet Srl as a Quality Assurance from June 2020 to December 2020. Rosita also gained valuable experience through an internship at Gruppo GPI from November 2019 to February 2020, where they focused on customer care and software for medical transfusion and blood donation applications.
Rosita's career in quality and regulatory management started at Eumed srl, where they collaborated on consultancy activities from March 2015 to July 2017.
Overall, Rosita Genovese has extensive experience in quality and regulatory management, with a focus on the healthcare industry.
Rosita Genovese has a strong educational background in engineering and clinical studies. Rosita pursued their undergraduate studies at the Università degli Studi di Padova, where they earned a Bachelor's degree in Biomedical Engineering. Following this, they continued their education at the Università degli Studi di Trieste and obtained a Master's degree in Clinical Engineering. Currently, Rosita is enrolled at the same university, pursuing a second-level Master's program in Clinical Engineering, expected to be completed between 2021 and 2022. Rosita'seducational focus throughout their academic journey has primarily been in the field of Clinical Engineering.
This person is not in any teams
Neuranix
NEURANIX, Transforming audiology diagnostics Neuranix is classified as an innovative company that develops and produces medical devices for people and pets. Through the acquisition of a new patented technology and thanks to the collaboration with specialists in the sector, we are able to develop solutions and specific applications in the audiological field, able to respond to the needs of humans and domestic companion animals. Research projects are carried out in collaboration with CNR (Italy’s National Research Institute), with important universities and specialist veterinary structures. Today Neuranix owns one patent in the audiological field and has two more pending for approval. These patents are currently applied in two products; Vet-Wave and Med-Wave. The first, developed for the veterinary world, is already being commercialized, while the second, for human use, will be launched at the end of 2022. For more info please contact info@neuranix.com.